Novartis AG is 212.8x more valuable than ATAI Life Sciences N.V. by market capitalization ($293.70 B vs $1.38 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ATAI | NVS |
|---|---|---|
| Market cap | $1.38 B | $293.70 B |
| US-listed rank | #2408 | #46 |
| Revenue (latest FY) | $308.00K | - |
| Net income (latest FY) | -$149.27M | - |
| Net margin | -48464.0% | - |
| SEC filings | 320 | 947 |
Novartis AG is 212.8x more valuable than ATAI Life Sciences N.V. by market capitalization ($293.70 B vs $1.38 B).
Full pages: ATAI Life Sciences N.V. and Novartis AG, or browse the full rankings.